VALIDOGEN
LIVE

Serial Number

79270687

Owner

VALIDOGEN GmbH

Attorney

Sheryl De Luca

Filing Date

Apr 2, 2019

Add to watchlist:

No watchlists yet
View on USPTO

VALIDOGEN Trademark

Serial Number: 79270687 • Registration: 6155753

VALIDOGEN is a trademark filed by VALIDOGEN GmbH on April 2, 2019. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VALIDOGEN GmbH (3 trademarks)

Parkring 18

Entity Type: 27

Trademark Details

Filing Date

April 2, 2019

Registration Date

September 22, 2020

Published for Opposition

July 7, 2020

Goods & Services

Chemical, biological, biochemical and biotechnological preparations, namely, for scientific and commercial purposes; biochemicals, namely, microorganisms in the form of, yeast and bacteria for use in protein expression; microbial production strains, namely, Komagataella phaffii strains known as Pichia pastoris and Escherichia coli strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries, and the laundry and cleaning preparations industries; microbial production strains for producing plasmid DNA; yeast strains, other than for making wine, medical or veterinary use; bacterial strains, other than for making wine, medical or veterinary use; proteins for use in science; proteins, not for scientific purposes and medical or veterinary use; proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries, and the laundry and cleaning preparations industries; proteins specifically, enzymes, for use in production processes, namely, for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; proteins for industrial use in particular for industrial, analytic and diagnostic purposes and cleaning purposes; enzymes derived from biotechnological processes for industrial use; nucleic recombinant acids, in particular plasmid DNA, for laboratory use; nucleic acids, in particular deoxyribonucleic acids, in particular for protein production

Consultancy, namely, providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development in the field of chemistry, biochemistry, and biotechnology; chemical and biological laboratory services; conducting of biological and biotechnological tests for commercial and scientific purposes; industrial biotechnological research; biotechnological research in the field of enzymatic synthesis; providing information on the subject of scientific research in the field of biochemistry and biotechnology; working on and evaluation of chemical syntheses; working on and evaluation of chemical analyses; research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; research and development services relating to biotechnical biochemistry science; development of proteins for use in pharmaceuticals, biotechnology, and medical and veterinary diagnostics; scientific research and development services, namely, production of proteins, plasmid DNA production, plasmid DNA purification, modification of proteins, purification of proteins, DNA manipulation and cell banking services for others; development of bioprocesses for protein production and plasmid DNA production; strain development services, namely, development of production strains for producing proteins; strain development, in particular the development of production strains for producing plasmid DNA; enzyme engineering for others; development of protein production processes for others; development of processes for producing plasmid DNA for others; plasmid DNA synthesis for others; development of plasmid DNA purification methods; development of protein purification methods

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 22, 2025 REM3
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 14, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 14, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 14, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 14, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 9, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 9, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 22, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 21, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 5, 2019 RFCS
REFUSAL PROCESSED BY MPU
Dec 5, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 14, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 13, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 12, 2019 MAFR
ASSIGNED TO EXAMINER
Nov 6, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 31, 2019 REPR